Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease

The TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute·2014·New England Journal of Medicine

DOI 10.1056/nejmoa1307095

Cited by (1,001)

Items 101–200 of 1,001

Unique roles of rare variants in the genetics of complex diseases in humans
Momozawa, Yukihide, Mizukami, Keijiro · 2021 · Journal of Human Genetics
Surprises from genetic analyses of lipid risk factors for atherosclerosis
Musunuru, Kiran, Kathiresan, Sekar · 2016 · Circulation Research
Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review
Oscarsson, Jan, Hurt-Camejo, Eva · 2017 · Lipids in Health and Disease
Systematic analysis of binding of transcription factors to noncoding variants
Jian Yan, Yunjiang Qiu, André Maurício Ribeiro dos Santos, Yimeng Yin, Yang Eric Li, Nick Vinckier, Naoki Nariai, Paola Benaglio, Anugraha Raman, Xiaoyu Li et al. · 2021 · Nature
Hypertriglyceridemia in the genomic era: a new paradigm
Lewis, Gary F., Xiao, Changting, Hegele, Robert A. · 2015 · Endocrine Reviews
Addressing dyslipidemic risk beyond LDL-cholesterol
Tall, Alan R., Thomas, David G., Gonzalez-Cabodevilla, Ainara G., Goldberg, Ira J. · 2022 · Journal of Clinical Investigation
Systemic and renal lipids in kidney disease development and progression
PATRICIA W. WAHL, Gloria Michelle Ducasa, Alessia Fornoni · 2015 · American Journal of Physiology-Renal Physiology
Advances in lipid-lowering therapy through gene-silencing technologies
Børge Grønne Nordestgaard, Stephen James Nicholls, Anne Langsted, Kausik Kumar Ray, Anne Tybjærg‐Hansen · 2018 · Nature Reviews Cardiology
Antisense oligonucleotides targeting translation inhibitory elements in 5′ UTRs can selectively increase protein levels
Xue‐hai Liang, Hong Sun, Wen Shen, Shiyu Wang, Joyee Yao, Michael T. Migawa, Huynh‐Hoa Bui, Sagar S. Damle, Stan Riney, Mark J. Graham et al. · 2017 · Nucleic Acids Research
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
Fruchart, Jean-Charles, Santos, Raul D., Aguilar-Salinas, Carlos, Aikawa, Masanori, Al Rasadi, Khalid, Amarenco, Pierre, Barter, Philip J., Ceska, Richard, Corsini, Alberto, Després, Jean-Pierre et al. · 2019 · Cardiovascular Diabetology
Mechanisms of Pediatric Inflammatory Bowel Disease
Joanna M. Peloquin, Gautam Goel, Eduardo J. Villablanca, Ramnik J. Xavier · 2016 · Annual Review of Immunology
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force
Maurizio Rocco Averna, Maciej Banach, Éric Bruckert, Heinz Drexel, Michel Farnier, Dan Ion Gaiță, Paolo Magni, Winfried März, L. Masana, Alberto Mello e Silva et al. · 2021 · Atherosclerosis
The risk of cardiovascular events with increased apolipoprotein CIII: a systematic review and meta-analysis
Wyler von Ballmoos, Moritz C., Haring, Bernhard, Sacks, Frank M. · 2015 · Journal of Clinical Lipidology
Protective alleles and modifier variants in human health and disease
Andrew Robert Harper, Shalini Nayee, Eric J. Topol · 2015 · Nature Reviews Genetics
Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis
Aryal, Binod, Singh, Abhishek K., Zhang, Xinbo, Varela, Luis, Rotllan, Noemi, Goedeke, Leigh, Chaube, Balkrishna, Camporez, Joao-Paulo, Vatner, Daniel F., Horvath, Tamas L. et al. · 2018 · JCI Insight
Recent Molecular Mechanisms and Beneficial Effects of Phytochemicals and Plant-Based Whole Foods in Reducing LDL-C and Preventing Cardiovascular Disease
Salman Ul Islam, Muhammad Bilal Ahmed, Haseeb Ahsan, Young Sup Lee · 2021 · Antioxidants
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues
Samuel C. R. Sherratt, Peter Libby, Matthew Jay Budoff, Deepak L. Bhatt, Richard Preston Mason · 2022 · Current Atherosclerosis Reports
AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes Patients
Kaufman, Allegra, Abuqayyas, Lubna, Denney, William S., Tillman, Erik J., Rolph, Tim · 2020 · Cell Reports Medicine
Plasma-derived Extracellular Vesicles Contain Predictive Biomarkers and Potential Therapeutic Targets for Myocardial Ischemic (MI) Injury
Esther Sok Hwee Cheow, Woo Chin Cheng, Chuen Neng Lee, Dominique P.V. de Kleijn, V. A. Sorokin, Siu Kwan Sze · 2016 · Molecular & Cellular Proteomics
The effect of LRRK2 loss-of-function variants in humans
Nicola Whiffin, Irina M. Armean, Aaron Kleinman, Jamie L. Marshall, Eric Vallabh Minikel, Julia K. Goodrich, Nicholas M. Quaife, Joanne B. Cole, Qingbo S. Wang, Konrad J. Karczewski et al. · 2020 · Nature Medicine
Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment
Jane F. Ferguson, Hooman Allayee, Robert Edgardo Gerszten, Folami Ideraabdullah, Penny M. Kris‐Etherton, José María Ordovás, Eric B. Rimm, Thomas J. Wang, Brian J. Bennett · 2016 · Circulation Cardiovascular Genetics
Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study
Kaltoft, Morten, Langsted, Anne, Nordestgaard, Børge G · 2020 · European Heart Journal
BMP gradient along the intestinal villus axis controls zonated enterocyte and goblet cell states
Joep Beumer, Jens Puschhof, Fjodor Yousef Yengej, Lianzheng Zhao, Adriana Martínez-Silgado, Marloes Blotenburg, Harry Begthel, Charelle Boot, Alexander van Oudenaarden, Ye‐Guang Chen et al. · 2022 · Cell Reports
Management of diabetic dyslipidemia: An update
Ishwarlal Jialal, Gurdeep Singh · 2019 · World Journal of Diabetes
High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real‐World Administrative Claims Analysis of Statin‐Treated Patients With High Residual Cardiovascular Risk
Toth, Peter P., Granowitz, Craig, Hull, Michael, Liassou, Djibril, Anderson, Amy, Philip, Sephy · 2018 · Journal of the American Heart Association
Genetics: Implications for Prevention and Management of Coronary Artery Disease
Themistocles L. Assimes, Robert Roberts · 2016 · Journal of the American College of Cardiology
Hyperlipidemia and hypothyroidism
Xin Su, Hua Peng, Xiang Chen, Xijie Wu, Bin Wang · 2022 · Clinica Chimica Acta
Apolipoprotein C-III
Alison B. Kohan · 2015 · Current Opinion in Endocrinology Diabetes and Obesity
Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese
Clara Sze-Man Tang, He Zhang, Chloe Y. Y. Cheung, Ming Xu, Jenny Chung-Yee Ho, Wei Zhou, Stacey Shawn Cherny, Yan Zhang, Oddgeir L. Holmen, Ka‐Wing Au et al. · 2015 · Nature Communications
APOC3 Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk
Anders Berg Wulff, Børge Grønne Nordestgaard, Anne Tybjærg‐Hansen · 2018 · Arteriosclerosis Thrombosis and Vascular Biology
PGRNseq
ALLAN S. GORDON, Robert S. Fulton, Xiang Qin, Elaine R. Mardis, Deborah A. Nickerson, Steve Scherer · 2016 · Pharmacogenetics and Genomics
Genetics of Triglycerides and the Risk of Atherosclerosis
Jacqueline S. Dron, Robert Alexander Hegele · 2017 · Current Atherosclerosis Reports
Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes
Toru Hiyoshi, Mutsunori Fujiwara, Yao Zemin · 2018 · Journal of Biomedical Research
The Role of Lipids and Lipoproteins in Atherosclerosis
MacRae F. Linton, Patricia G. Yancey, Sean S. Davies, W. Gray Jerome, Edward F. Linton, Wen‐Liang Song, Amanda C. Doran, Kasey C. Vickers · 2015 · Europe PMC (PubMed Central)
Genome editing: the road of CRISPR/Cas9 from bench to clinic
Ayman Eid, Magdy M. Mahfouz · 2016 · Experimental & Molecular Medicine
A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels
Sumeet A. Khetarpal, Xuemei Zeng, John S. Millar, Cecilia Vitali, Amritha Varshini Hanasoge Somasundara, Paolo Zanoni, James A. Landro, Nicole Barucci, William J. Zavadoski, Zhiyuan Sun et al. · 2017 · Nature Medicine
Coronary Artery Disease Genetics Enlightened by Genome-Wide Association Studies
Thorsten Kessler, Heribert Schunkert · 2021 · JACC Basic to Translational Science
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Michaeli, Daniel Tobias, Michaeli, Julia Caroline, Albers, Sebastian, Boch, Tobias, Michaeli, Thomas · 2023 · American Journal of Cardiovascular Drugs
Triglycerides and risk of atherosclerotic cardiovascular disease: An update
Michel Farnier, Marianne Zeller, David Masson, Yves Cottin · 2021 · Archives of cardiovascular diseases
Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
Jenny E. Kanter, Baohai Shao, Farah Kramer, Shelley Barnhart, Masami Shimizu‐Albergine, Tomáš Vaisar, Mark J. Graham, Rosanne M. Crooke, Clarence R. Manuel, Rebecca A. Haeusler et al. · 2019 · Journal of Clinical Investigation
High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts
Majken K. Jensen, Sarah A. Aroner, Kenneth Jay Mukamal, Jeremy D. Furtado, Wendy S. Post, Michael Y. Tsai, Anne Marie Tjønneland, Joseph F. Polak, Eric B. Rimm, Kim Overvad et al. · 2017 · Circulation
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease
Julia Brandts, Kausik Kumar Ray · 2023 · Nature Reviews Cardiology
National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk
Orringer, Carl E., Jacobson, Terry A., Maki, Kevin C. · 2019 · Journal of Clinical Lipidology
Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results
Yang, Xiaohong, Lee, Sang-Rok, Choi, Yun-Seok, Alexander, Veronica J., Digenio, Andres, Yang, Qingqing, Miller, Yury I., Witztum, Joseph L., Tsimikas, Sotirios · 2016 · Journal of Lipid Research
Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD
Marja‐Riitta Taskinen, Chris J. Packard, Jan Borén · 2019 · Current Atherosclerosis Reports
Genetics of coronary artery disease in the post‐GWAS era
Zhifen Chen, Heribert Schunkert · 2021 · Journal of Internal Medicine
Personalized medicine in diabetes mellitus: current opportunities and future prospects
Jeffrey W. Kleinberger, Toni I. Pollin · 2015 · Annals of the New York Academy of Sciences
Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism
Bastian Ramms, Philip L.S.M. Gordts · 2018 · Current Opinion in Lipidology
Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism
Reyes-Soffer, Gissette, Sztalryd, Carol, Horenstein, Richard B., Holleran, Stephen, Matveyenko, Anastasiya, Thomas, Tiffany, Nandakumar, Renu, Ngai, Colleen, Karmally, Wahida, Ginsberg, Henry N. et al. · 2019 · Arteriosclerosis, Thrombosis, and Vascular Biology
Glucagon-Like Peptide-2 Regulates Release of Chylomicrons From the Intestine
Satya Dash, Changting Xiao, Cecilia Morgantini, Philip W. Connelly, Bruce W. Patterson, Gary F. Lewis · 2014 · Gastroenterology
Polygenic Hyperlipidemias and Coronary Artery Disease Risk
Pietari Ripatti, Joel T Rämö, Nina J. Mars, Yu Fu, Jake Lin, Sanni Söderlund, Christian Benner, Ida Surakka, Tuomo Kiiskinen, Aki S. Havulinna et al. · 2020 · Circulation Genomic and Precision Medicine
Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA in Dyslipidemias
Katzmann, Julius L., Packard, Chris J., Chapman, M. John, Katzmann, Isabell, Laufs, Ulrich · 2020 · Journal of the American College of Cardiology
Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?: New Insights From the Framingham Offspring Study
Bartlett, Jacquelaine, Predazzi, Irene M., Williams, Scott M., Bush, William S., Kim, Yeunjung, Havas, Stephen, Toth, Peter P., Fazio, Sergio, Miller, Michael · 2016 · Circulation: Cardiovascular Quality and Outcomes
Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia
Bo Hu, Bo Li, Kun Li, Yuanyuan Liu, Chunhui Li, Lulu Zheng, Mengjie Zhang, Tongren Yang, Shuai Guo, Xiyu Dong et al. · 2022 · Science Advances
Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy
Annema, Wijtske, von Eckardstein, Arnold · 2016 · Translational Research
Guidelines for Large-Scale Sequence-Based Complex Trait Association Studies: Lessons Learned from the NHLBI Exome Sequencing Project
Paul Livermore Auer, Alex P. Reiner, Gao Wang, Hyun Min Kang, Gonçalo R. Abecasis, David Altshuler, Michael J. Bamshad, Deborah A. Nickerson, Russell P. Tracy, Stephen S. Rich et al. · 2016 · The American Journal of Human Genetics
Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease
Sjaarda, Jennifer, Gerstein, Hertzel, Chong, Michael, Yusuf, Salim, Meyre, David, Anand, Sonia S., Hess, Sibylle, Paré, Guillaume · 2018 · Journal of the American College of Cardiology
A new dawn for managing dyslipidemias: The era of rna-based therapies
Chiara Macchi, Cesare Riccardo Sirtori, Alberto Corsini, Raul Dias Santos, Gerald Francis Watts, Massimiliano Ruscica · 2019 · Pharmacological Research
Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future options
Ray, Kausik K, Corral, Pablo, Morales, Enrique, Nicholls, Stephen J · 2019 · The Lancet
Cohort Profile: Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS)
Harry L. Hébert, Bridget Shepherd, Keith Milburn, Abirami Veluchamy, Weihua Meng, Fiona Carr, Louise A. Donnelly, Roger Tavendale, Graham Leese, Helen Martina Colhoun et al. · 2017 · International Journal of Epidemiology
Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism
Huixing Liu, Daoquan Peng · 2022 · Endocrine Connections
Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future
Yasuhiro Watanabe, Ichiro Tatsuno · 2017 · Expert Review of Clinical Pharmacology
Genetics of atrial fibrillation: from families to genomes
Christophersen, Ingrid E, Ellinor, Patrick T · 2016 · Journal of Human Genetics
Family-Based Quantitative Trait Meta-Analysis Implicates Rare Noncoding Variants in DENND1A in Polycystic Ovary Syndrome
Matthew Dapas, Ryan K. Sisk, Richard S. Legro, Margrit Urbanek, Andrea Elizabeth Dunaif, M. Geoffrey Hayes · 2019 · The Journal of Clinical Endocrinology & Metabolism
Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding
Allan D. Sniderman, Patrick Couture, Seth Shay Martin, J DEGRAAF, Patrick R. Lawler, William C. Cromwell, John T. Wilkins, George Thanassoulis · 2018 · Journal of Lipid Research
The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities
Derek M. Erion, Hyun‐Jun Park, Hui‐Young Lee · 2016 · BMB Reports
Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
Marja‐Riitta Taskinen, Jan Borén · 2016 · Current Atherosclerosis Reports
Triglyceride-rich lipoproteins and remnants: targets for therapy?
Dallinga-Thie, Geesje M., Kroon, Jeffrey, Borén, Jan, Chapman, M. John · 2016 · Current Cardiology Reports
Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2)
Futatsugi, Kentaro, Kung, Daniel W., Orr, Suvi T. M., Cabral, Shawn, Hepworth, David, Aspnes, Gary, Bader, Scott, Bian, Jianwei, Boehm, Markus, Carpino, Philip A. et al. · 2015 · Journal of Medicinal Chemistry
RNA Therapeutics in Cardiovascular Precision Medicine
Ageliki Laina, Aikaterini Gatsiou, Georgios A. Georgiopoulos, Kimon S. Stamatelopoulos, Konstantinos Stellos · 2018 · Frontiers in Physiology
GPIHBP1 and Plasma Triglyceride Metabolism
Loren G. Fong, Stephen G. Young, Anne P. Beigneux, André Bensadoun, Monika Oberer, Haibo Jiang, Michael Ploug · 2016 · Trends in Endocrinology and Metabolism
Is a High HDL-Cholesterol Level Always Beneficial?
Beata Franczyk, Jacek Rysz, Janusz Ławiński, Magdalena Rysz-Górzyńska, Anna Gluba-Brzózka · 2021 · Biomedicines
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease
Akihiro Nomura, Hong‐Hee Won, Amit V. Khera, Fumihiko Takeuchi, Kaoru Ito, Shane McCarthy, Connor A. Emdin, Derek M. Klarin, Pradeep Natarajan, Seyedeh Maryam Zekavat et al. · 2017 · Circulation Research
Triglycerides on the rise: should we swap seats on the seesaw?
Libby, Peter · 2015 · European Heart Journal
Highlighting Residual Atherosclerotic Cardiovascular Disease Risk
Yunosuke Matsuura, Jenny E. Kanter, Karin Bornfeldt · 2018 · Arteriosclerosis Thrombosis and Vascular Biology
Genetics, Dyslipidemia, and Cardiovascular Disease: New Insights
Stein, Ricardo, Ferrari, Filipe, Scolari, Fernando · 2019 · Current Cardiology Reports
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi · 2022 · Diabetes & Metabolism Journal
Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics
William E. Boden, Deepak L. Bhatt, Peter Paul Toth, Kausik Kumar Ray, M. John Chapman, Thomas Felix Lüscher · 2019 · European Heart Journal
Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3)
Henry N. Ginsberg, Ira J. Goldberg · 2022 · Arteriosclerosis Thrombosis and Vascular Biology
The genomic landscape of African populations in health and disease
Charles N. Rotimi, Amy R. Bentley, Ayo Priscille Doumatey, Guanjie Chen, Daniel Shriner, Adebowale Adeyemo · 2017 · Human Molecular Genetics
Human Genetics of Obesity and Type 2 Diabetes Mellitus
Erik Ingelsson, Mark I. McCarthy · 2018 · Circulation Genomic and Precision Medicine
Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products
Fialkow, Jonathan · 2016 · American Journal of Cardiovascular Drugs
Association of Genetically Enhanced Lipoprotein Lipase–Mediated Lipolysis and Low-Density Lipoprotein Cholesterol–Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes
Lotta, Luca A., Stewart, Isobel D., Sharp, Stephen J., Day, Felix R., Burgess, Stephen, Luan, Jian’an, Bowker, Nicholas, Cai, Lina, Li, Chen, Wittemans, Laura B. L. et al. · 2018 · JAMA Cardiology
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism
Antonina Giammanco, Rossella Spina, Angelo Baldassare Cefalu, Maurizio Rocco Averna · 2023 · Current Atherosclerosis Reports
Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 Diabetics
Arman Qamar, Sumeet A. Khetarpal, Amit V. Khera, Atif Qasim, Daniel James Rader, Muredach P. Reilly · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
Genetics of Lipid and Lipoprotein Disorders and Traits
Jacqueline S. Dron, Robert Alexander Hegele · 2016 · Current Genetic Medicine Reports
Monocytes and macrophages as protagonists in vascular complications of diabetes
Kanter, Jenny E., Hsu, Cheng-Chieh, Bornfeldt, Karin E. · 2020 · Frontiers in Cardiovascular Medicine
The atherogenic dyslipidemia complex and novel approaches to cardiovascular disease prevention in diabetes
Stahel, Priska, Xiao, Changting, Hegele, Robert A., Lewis, Gary F. · 2018 · Canadian Journal of Cardiology
Molecular genetics of coronary artery disease
Kouichi Ozaki, Toshihiro Tanaka · 2015 · Journal of Human Genetics
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia
Bergmark, Brian A., Marston, Nicholas A., Prohaska, Thomas A., Alexander, Veronica J., Zimerman, Andre, Moura, Filipe A., Kang, Yu Mi, Weinland, Julia, Murphy, Sabina A., Goodrich, Erica L. et al. · 2025 · New England Journal of Medicine
Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis
Angela Pirillo, Monika Svecla, Alberico Luigi Catapano, Adriaan Georgius Holleboom, Giuseppe Danilo Norata · 2020 · Cardiovascular Research
Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
Baihui Zhang, Fan Yin, Ya-Nan Qiao, Shoudong Guo · 2022 · Frontiers in Molecular Biosciences
Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk
Julian C. van Capelleveen, Sophie J. Bernelot Moens, Xiaohong Yang, John J.P. Kastelein, Nicholas J. Wareham, Aeilko H. Zwinderman, Erik S.G. Stroes, Joseph Lee Witztum, G. Kees Hovingh, Kay‐Tee Khaw et al. · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study
Borén, Jan, Watts, Gerald F., Adiels, Martin, Söderlund, Sanni, Chan, Dick C., Hakkarainen, Antti, Lundbom, Jesper, Lundbom, Nina, Matikainen, Niina, Kahri, Juhani et al. · 2015 · Arteriosclerosis, Thrombosis, and Vascular Biology
New Therapeutic Approaches to the Treatment of Dyslipidemia
Daniel James Rader · 2016 · Cell Metabolism
Hypertriglyceridemia—causes, significance, and approaches to therapy
Santos-Baez, Leinys S., Ginsberg, Henry N. · 2020 · Frontiers in Endocrinology
Triglyceride-Rich Lipoproteins and Coronary Artery Disease Risk
Sumeet A. Khetarpal, Daniel James Rader · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
Triglycerides and triglyceride-rich lipoproteins in the development and progression of atherosclerosis
Giuliano Generoso, Carolina Castro Porto Silva Janovsky, Márcio Sommer Bittencourt · 2019 · Current Opinion in Endocrinology Diabetes and Obesity
Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia
Chao Liu, Keith P. Gates, Longhou Fang, Marcelo J. Amar, Dina A. Schneider, Honglian Geng, Wei Guo Huang, Jungsu Kim, Jennifer Pattison, Jian Zhang et al. · 2015 · Disease Models & Mechanisms
RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia
Gaudet, Daniel, Clifton, Peter, Sullivan, David, Baker, John, Schwabe, Christian, Thackwray, Susan, Scott, Russell, Hamilton, James, Given, Bruce, Melquist, Stacey et al. · 2023 · NEJM Evidence